PCK2
Basic information
Region (hg38): 14:24094053-24110598
Links
Phenotypes
GenCC
Source:
- phosphoenolpyruvate carboxykinase deficiency, mitochondrial (Limited), mode of inheritance: AR
- phosphoenolpyruvate carboxykinase deficiency (Supportive), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
- Phosphoenolpyruvate carboxykinase deficiency, mitochondrial (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PCK2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 26 | 35 | ||||
missense | 110 | 10 | 125 | |||
nonsense | 5 | |||||
start loss | 0 | |||||
frameshift | 6 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 6 | |||||
splice region | 4 | 2 | 1 | 7 | ||
non coding | 11 | 13 | ||||
Total | 1 | 0 | 127 | 48 | 14 |
Highest pathogenic variant AF is 0.000171
Variants in PCK2
This is a list of pathogenic ClinVar variants found in the PCK2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-24094411-C-T | Benign (Jan 29, 2024) | |||
14-24094416-T-G | Uncertain significance (May 11, 2023) | |||
14-24094417-G-C | not specified | Uncertain significance (Mar 30, 2024) | ||
14-24094422-G-A | not specified | Uncertain significance (Jul 12, 2023) | ||
14-24094423-C-A | Likely benign (Jan 07, 2024) | |||
14-24094439-G-A | Retinitis pigmentosa 27 | Uncertain significance (Mar 29, 2024) | ||
14-24096872-T-C | Likely benign (Feb 13, 2023) | |||
14-24096879-G-A | Likely benign (Nov 21, 2023) | |||
14-24096930-C-G | not specified • Phosphoenolpyruvate carboxykinase deficiency, mitochondrial | Conflicting classifications of pathogenicity (Jan 09, 2024) | ||
14-24096935-C-T | not specified | Uncertain significance (Dec 15, 2023) | ||
14-24096936-G-A | Uncertain significance (Dec 11, 2023) | |||
14-24096954-G-A | not specified | Uncertain significance (Dec 11, 2023) | ||
14-24096956-G-A | not specified | Uncertain significance (Oct 05, 2022) | ||
14-24096983-C-T | Uncertain significance (Dec 05, 2022) | |||
14-24097012-C-T | Conflicting classifications of pathogenicity (Jan 08, 2024) | |||
14-24097019-C-A | Uncertain significance (Jan 14, 2023) | |||
14-24097019-C-T | Phosphoenolpyruvate carboxykinase deficiency, mitochondrial • not specified | Uncertain significance (Dec 15, 2022) | ||
14-24097024-G-T | Likely benign (Nov 27, 2023) | |||
14-24097041-T-C | Uncertain significance (Jun 06, 2023) | |||
14-24097049-T-G | not specified | Uncertain significance (Dec 01, 2022) | ||
14-24097052-G-A | PCK2-related disorder | Benign (Jan 16, 2024) | ||
14-24097059-C-G | not specified | Uncertain significance (Nov 22, 2022) | ||
14-24097080-C-T | not specified | Likely benign (Sep 09, 2021) | ||
14-24097093-G-A | Uncertain significance (Feb 17, 2022) | |||
14-24097112-C-T | Uncertain significance (Feb 18, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PCK2 | protein_coding | protein_coding | ENST00000216780 | 10 | 16546 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.75e-23 | 0.000368 | 124495 | 2 | 1251 | 125748 | 0.00499 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.203 | 418 | 407 | 1.03 | 0.0000251 | 4144 |
Missense in Polyphen | 204 | 197.53 | 1.0328 | 2008 | ||
Synonymous | 0.693 | 139 | 150 | 0.928 | 0.00000859 | 1331 |
Loss of Function | -0.244 | 34 | 32.5 | 1.05 | 0.00000213 | 280 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00896 | 0.00894 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000870 | 0.000870 |
Finnish | 0.000235 | 0.000231 |
European (Non-Finnish) | 0.00782 | 0.00777 |
Middle Eastern | 0.000870 | 0.000870 |
South Asian | 0.00193 | 0.00190 |
Other | 0.00572 | 0.00572 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the conversion of oxaloacetate (OAA) to phosphoenolpyruvate (PEP), the rate-limiting step in the metabolic pathway that produces glucose from lactate and other precursors derived from the citric acid cycle. {ECO:0000250}.;
- Disease
- DISEASE: Mitochondrial phosphoenolpyruvate carboxykinase deficiency (M-PEPCKD) [MIM:261650]: Metabolic disorder resulting from impaired gluconeogenesis. It is a rare disease with less than 10 cases reported in the literature. Clinical characteristics include hypotonia, hepatomegaly, failure to thrive, lactic acidosis and hypoglycemia. Autopsy reveals fatty infiltration of both the liver and kidneys. The disorder is transmitted as an autosomal recessive trait. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- PI3K-Akt signaling pathway - Homo sapiens (human);Citrate cycle (TCA cycle) - Homo sapiens (human);Pyruvate metabolism - Homo sapiens (human);Adipocytokine signaling pathway - Homo sapiens (human);Glycolysis / Gluconeogenesis - Homo sapiens (human);Insulin resistance - Homo sapiens (human);FoxO signaling pathway - Homo sapiens (human);Proximal tubule bicarbonate reclamation - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Glucagon signaling pathway - Homo sapiens (human);PPAR signaling pathway - Homo sapiens (human);Insulin signaling pathway - Homo sapiens (human);Adipogenesis;Transcription factor regulation in adipogenesis;PPAR signaling pathway;PI3K-Akt Signaling Pathway;DNA Damage Response (only ATM dependent);Metabolism of carbohydrates;Citrate cycle;Glycolysis and Gluconeogenesis;Metabolism;TCA cycle;Glucocorticoid receptor regulatory network;gluconeogenesis;Gluconeogenesis;Glucose metabolism
(Consensus)
Recessive Scores
- pRec
- 0.818
Intolerance Scores
- loftool
- 0.999
- rvis_EVS
- 0.27
- rvis_percentile_EVS
- 70.75
Haploinsufficiency Scores
- pHI
- 0.211
- hipred
- N
- hipred_score
- 0.213
- ghis
- 0.432
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 1.00
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pck2
- Phenotype
Gene ontology
- Biological process
- pyruvate metabolic process;gluconeogenesis;propionate catabolic process;cellular response to insulin stimulus;response to lipid;response to starvation;glycerol biosynthetic process from pyruvate;hepatocyte differentiation;cellular response to glucose stimulus;cellular response to dexamethasone stimulus
- Cellular component
- mitochondrion;mitochondrial matrix;cytosol
- Molecular function
- phosphoenolpyruvate carboxykinase activity;phosphoenolpyruvate carboxykinase (GTP) activity;protein binding;GTP binding;manganese ion binding